Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. patents potassium channel blockers

Aug. 16, 2016

Takeda Pharmaceutical reports MGAT2 inhibitors

Aug. 16, 2016

Wockhardt reports beta-lactamase inhibitors

Aug. 12, 2016

MedImmune develops TB4 fusion polypeptides

Aug. 12, 2016

Medshine Discovery discloses JAK inhibitors

Aug. 12, 2016

Bayer Pharma patents mitotic checkpoint serine/threonine-protein kinase BUB1 inhibitors

Aug. 12, 2016

Roche patent reveals anti-HBV agents

Aug. 11, 2016

Jn Therapeutics develops JAK1 inhibitors

Aug. 11, 2016

Pfizer patents retinoid RORgamma t receptor antagonists and IL-17 production inhibitors

Aug. 11, 2016

Actelion Pharmaceuticals develops CXCR3 receptor antagonists

Aug. 10, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...